Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Open-label, Multi-center, Community-based Trial in Asia Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.

NCT00160654 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00160654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Open-label, Multi-center, Community-based Trial in Asia Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.
Lead sponsor
UCB Pharma
Phase
Phase 4
Overall status
Completed
Start date
November 24, 2003
Completion date
December 12, 2006
Enrollment
251 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial